Please join us for an Astellas Pharma US, Inc. and Medivation, Inc. presentation of XTANDI® in the treatment of metastatic castration-resistant prostate cancer (mCRPC). Haydee Kapin, DNP, ARNP, AOCN, from the University of Miami will walk you through an overview of mCRPC, discuss considerations for the treatment of patients with mCRPC, present patient cases, and review the use of XTANDI and important safety information. We are looking forward to your attendance.
This program is sponsored by Astellas / Medivation
